Can You Get Mounjaro Free on the NHS? The Real Answer

The NHS does prescribe tirzepatide (Mounjaro), but only within a tightly defined phased rollout tied to BMI and specific health conditions.
As of summer 2026, the first cohort requires a BMI of 40 or above plus four or more qualifying conditions; a second cohort (BMI 35–39.9 with four or more conditions) was activated in June 2026.
Even if you meet the criteria on paper, your GP's practice must be participating in the scheme — participation is optional, so availability varies by area.
People who do not meet the NHS threshold, or do not want to wait, can access Mounjaro through a regulated private pharmacy following a clinical assessment with a GPhC-registered prescriber.

Mounjaro is available on the NHS, but not freely or widely — strict eligibility criteria and a phased rollout mean most people asking this question will not qualify yet. The NHS route exists, but it is narrower than many readers expect. Here is what the rules actually say, and what your options are if you fall outside them.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The NHS criteria, the phasing, and what to do if you don't qualify

The myth: 'Mounjaro is now free for anyone who wants it on the NHS'

Since NICE recommended tirzepatide in December 2024, there has been a persistent belief that Mounjaro is now simply available on the NHS like any other medicine. It isn't. NICE's appraisal (TA1026) set out a phased rollout tied to very specific BMI and comorbidity thresholds, not a general prescription anyone can request. The recommendation exists, but the access is rationed deliberately, partly because of supply and cost, and partly because the NHS model pairs the medicine with structured wraparound support that has to be commissioned before prescribing begins.

A quick way to check your starting position: look up the five qualifying conditions listed by NHS England (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, type 2 diabetes) and count honestly how many apply to you. If fewer than four do, you almost certainly fall outside the current NHS cohorts. That takes under a minute and saves a longer conversation with a GP who may not be able to help.

The full picture of how Mounjaro sits within NHS commissioning is worth reading if you want the detail behind each cohort's launch date.

What the NHS actually requires right now

Under the phased NHS rollout, the first cohort (open since June 2025) requires a BMI of 40 or above plus four or more of the five qualifying conditions listed above. A second cohort, for BMI 35–39.9 with the same four-condition threshold, was formally activated on 23 June 2026. A third cohort (BMI 40-plus with three conditions) is expected around March 2027. Lower BMI thresholds apply for South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds under NICE TA1026.

There is a further catch. From April 2026, some GP practices can prescribe under the new QOF arrangements, but participation is optional. Your practice may not be set up for it. And every NHS patient must be enrolled in a diet and activity support programme alongside the medicine. The medicine alone is not the offer; structured support is part of the package, and commissioning that takes time. Whether your GP can prescribe Mounjaro depends on your local ICB and whether your practice has signed up.

Worth noting: even meeting every criterion on paper does not guarantee a prescription. The prescriber assesses the whole clinical picture, and availability at practice level varies considerably across England. Scotland, Wales and Northern Ireland each operate different access arrangements.

If the NHS route is closed to you right now

For people who do not meet the current NHS thresholds (or who do meet them but face a long wait) a private prescription is the legal alternative. Mounjaro is a prescription-only medicine, which means the only legitimate route, NHS or private, is a clinical assessment followed by a prescriber's decision. Buying Mounjaro through a regulated UK online pharmacy follows the same legal and clinical framework: identity verification, a prescriber reviewing your consultation, and medicines dispensed from a GPhC-registered pharmacy. The difference is speed and eligibility, private criteria follow the licensed thresholds (BMI 30-plus, or 27-plus with a qualifying condition) rather than the NHS's narrower cohort rules.

The cost of Mounjaro privately is a fair question to ask at this point. Private prices vary by dose and provider, and a legitimate price always includes the clinical assessment and prescription, not just the pen. Anyone offering Mounjaro without a clinical assessment attached is not operating within the law, and if you have come across tirzepatide being sold through channels that feel unclear, our guide to whether Synedica tirzepatide is legit walks through how to judge whether a provider is operating within the rules. Report suspect sellers via Yellow Card.

At nume (at our GPhC-registered pharmacy) a named prescriber, not an algorithm, reads your consultation the same day. If you're clinically suitable and order by midday Monday to Friday, treatment is dispatched the same day. That is not a substitute for the NHS; it is a different route, for people the NHS hasn't reached yet. Start your free consultation if you'd like to explore whether private treatment is right for you.

The honest summary

Mounjaro is not free in any meaningful general sense. It is free for a specific, narrowing group of NHS patients who meet strict criteria, whose GP practice is participating, and who can access the wraparound support the NHS requires. That group is expanding slowly through the phased rollout, but it remains a minority of the people who would benefit clinically.

For everyone else, the options are to wait (either for NHS criteria to widen or for your practice to join the scheme) or to pursue a private prescription through a properly regulated service. Whether there is any other route to getting tirzepatide without cost is a separate question with its own answer. What there is not, legally, is a shortcut: no online seller can offer this medicine free from clinical oversight, and any that appears to is one to avoid.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions